Silo Pharma, Inc. (SILO)
2.15
0.00 (0.00%)
USD |
NASDAQ |
Sep 10, 16:00
2.15
0.00 (0.00%)
After-Hours: 20:00
Silo Pharma Total Assets (Quarterly) : 5.952M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 5.952M |
| March 31, 2026 | 7.018M |
| December 31, 2025 | 7.605M |
| September 30, 2025 | 6.385M |
| June 30, 2025 | 6.652M |
| March 31, 2025 | 5.90M |
| December 31, 2024 | 7.412M |
| September 30, 2024 | 8.567M |
| June 30, 2024 | 8.038M |
| March 31, 2024 | 6.941M |
| December 31, 2023 | 7.746M |
| September 30, 2023 | 8.987M |
| June 30, 2023 | 10.25M |
| March 31, 2023 | 11.02M |
| December 31, 2022 | 11.64M |
| September 30, 2022 | 13.05M |
| June 30, 2022 | 9.045M |
| March 31, 2022 | 9.716M |
| December 31, 2021 | 10.49M |
| September 30, 2021 | 11.39M |
| June 30, 2021 | 5.004M |
| March 31, 2021 | 5.501M |
| December 31, 2020 | 1.427M |
| September 30, 2020 | 2.204M |
| June 30, 2020 | 2.796M |
| Date | Value |
|---|---|
| March 31, 2020 | 0.4038M |
| December 31, 2019 | 0.4938M |
| September 30, 2019 | 0.3865M |
| June 30, 2019 | 0.5355M |
| March 31, 2019 | 0.7509M |
| December 31, 2018 | |
| September 30, 2018 | 1.435M |
| June 30, 2018 | 1.350M |
| March 31, 2018 | 1.693M |
| December 31, 2017 | 1.641M |
| September 30, 2017 | 1.427M |
| June 30, 2017 | 1.936M |
| March 31, 2017 | 2.082M |
| December 31, 2016 | 1.300M |
| September 30, 2016 | 1.439M |
| June 30, 2016 | 1.894M |
| March 31, 2016 | 2.293M |
| December 31, 2015 | 2.450M |
| September 30, 2015 | 2.416M |
| June 30, 2015 | 2.864M |
| March 31, 2015 | 2.836M |
| December 31, 2014 | 2.772M |
| September 30, 2014 | 2.822M |
| June 30, 2014 | 2.494M |
| March 31, 2014 | 2.933M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
| Savara, Inc. | 192.14M |
| Vericel Corp. | 502.87M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.066M |
| Shareholders Equity (Quarterly) | 4.886M |
| Current Ratio | 5.361 |